Hutt, who was retired partner in residence for Covington & Burling, the Washington firm he rejoined after leaving his post as ...

Australian sunscreen brand Ultra Violette Skincare has beaten global beauty giants to become the first brand to launch a US ...

The megablockbuster helped 40% of children reduce BMI below the obesity threshold at 68 weeks, compared with 0% for placebo, ...

What's happening, why it matters and what's next at FDA. This edition covers a one month extension to the deadline which will ...

The second quarter of 2026 showed a reversal from Q1's seasonal softness, with nine of the world's 10 best-selling drugs ...

DEA placed Haisco's newly approved anesthetic Cypsedo (cipepofol) in Schedule IV, the final regulatory hurdle before the ...

The FDA reiterated that it will not accept foreign clinical trial data generated at site where inspections were denied and ...

One hundred days into the Bundibugyo virus outbreak, rapid diagnostics have seen strong progress, but true point-of-care ...

FDA reaffirms fluoropolymers such as PTFE are safe and irreplaceable in devices, but the reprieve is US-only: an EU REACH ...

Another blow for Novo after data monitoring committee sees little hope of success for the anti-inflammation drug ziltivekimab ...

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical ...

Stay up to date on regulatory guidelines from around the world with the Pink Sheet’s Guidance Tracker. The complete Global ...